Tickerover
Sign inStart free→
Healthcare

LIVN Stock Analysis

LivaNova PLC · current price $80.34 (+0.36% today)

Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★★
Top Tier
📊

The six-pillar scorecard

Momentum
51
Drifting higher
price trend
Growth
27
Barely growing
sales & profit growth
Quality
93
High quality
profitability & balance sheet
Valuation
80
Looks cheap
is the price fair?
Sentiment
49
Mixed views
analyst & crowd mood
Risk
73
Low risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
GrowthGrowth: 7878RSI zoneRSI zone: 100100Relative strengthRelative strength: 8585FundamentalsFundamentals: 9191Earnings qualityEarnings quality: 8989Analyst consensusAnalyst consensus: 7070Breakout proximityBreakout proximity: 6363
Margin profileWhat survives each step down the income statement.
GrossGross: 67.7%67.7%OperatingOperating: 13.5%13.5%NetNet: 12.8%12.8%Free cash flowFree cash flow: 10.1%10.1%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +15.1% vs estimate+15%2026-062026-03: +9.3% vs estimate+9%2026-032025-12: +5.6% vs estimate+6%2025-122025-09: +20.4% vs estimate+20%2025-09
👁

Hype Check

Reading LIVN’s price and volume history…

✓

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading LIVN’s filings…

📣

Latest earnings

LAST EARNINGS LivaNova PLC (LIVN)

Latest earnings

EPS
$1.11 vs $0.92 est · +20.4% vs estimate BEAT
Revenue
$390.6M · +9.2% YoY
Stock reaction (1M)
-0.9%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
23.6×
Forward P/E
17.2×
PEG
0.93
Price / Sales
3.0×
Price / Book
3.3×
EV / EBITDA
16.4×
Analyst target
$88.80
Target range
$75.00 – $100.00
Implied upside
+10.5%
🩺

Financial health

Gross margin
67.7%
Operating margin
13.5%
Net margin
12.8%
FCF margin
10.1%
Return on equity
15.4%
Debt / equity
0.27
Revenue growth YoY
+10.8%
EPS growth YoY
+2.9%
📈

Technicals

$48.8252-week range$85.76
RSI (14)
52
50-day MA
$80.51
200-day MA
$69.13
ATR (14)
2.28
Beta
0.87
1-month return
-0.9%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$1.11$0.92+20.4%Beat
2025-12-31$0.86$0.81+5.6%Beat
2026-03-31$0.98$0.90+9.3%Beat
2026-06-30$1.26$1.09+15.1%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.10%
Beta
0.87
📰

Latest news on LIVN

🔗

Similar stocks in Healthcare

DXCMDexCom, Inc.SHCSotera Health CompanyCONConcentra Group Holdings Parent, IACADACADIA Pharmaceuticals Inc.HALOHalozyme Therapeutics, Inc.WATWaters Corporation

View all Healthcare stocks →

❓

Frequently asked

What is LIVN's Quant Score?

LivaNova PLC (LIVN) currently has a TickerMover Quant Score of 69/100, rated ★★★★★ Top Tier. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is LivaNova PLC (LIVN) a buy?

TickerMover does not give buy or sell recommendations. LIVN scores 69/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is LIVN's score updated?

LIVN's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Tickerover

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for LIVN →
TickerMover is a research tool, not financial advice. Quant Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.